Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cryptogenic organizing pneumonia (COP) is a form of idiopathic interstitial pneumonia characterized pathologically by organizing pneumonia (OP) that presents with non-specific flu-like symptoms, as well as cough and dyspnea and where no etiological agent is found.
Biomarker and diagnostic research for cryptogenic organizing pneumonia has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
4 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE3, 1 PHASE2. Research is primarily sponsored by academic and government institutions.
160 publications have been identified in PubMed for cryptogenic organizing pneumonia. Research spans Case Report / Case Series (41%), Review / Meta-Analysis (25%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 66 |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 6:34 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 40 | 25% |
Testing and diagnosis research | 20 | 13% |
Disease patterns and progression | 18 | 11% |
Clinical study results | 7 | 4% |
Laboratory research | 7 | 4% |
Other research | 1 | 1% |
New treatment approaches | 1 | 1% |
Habib R (2026). [PMID: 42165312](https://pubmed.ncbi.nlm.nih.gov/42165312/). *J Investig Med High Impact Case Rep*. [Case Report / Case Series]
Ukonmaanaho EM (2026). [PMID: 42120537](https://pubmed.ncbi.nlm.nih.gov/42120537/). *Pediatr Res*. [Clinical Trial Publication]
Beeskow AB (2026). [PMID: 41665681](https://pubmed.ncbi.nlm.nih.gov/41665681/). *Radiologie (Heidelb)*. [Review / Meta-Analysis]
Takeuchi N (2026). [PMID: 42211576](https://pubmed.ncbi.nlm.nih.gov/42211576/). *Respir Med Case Rep*. [Case Report / Case Series]
Lange SM (2026). [PMID: 32644520](https://pubmed.ncbi.nlm.nih.gov/32644520/). *Unknown Journal*. [Epidemiology / Natural History]
Yamaguchi K (2026). [PMID: 41417148](https://pubmed.ncbi.nlm.nih.gov/41417148/). *Breast Cancer*. [Review / Meta-Analysis]
Kumar G (2026). [PMID: 41812990](https://pubmed.ncbi.nlm.nih.gov/41812990/). *Chest*. [Epidemiology / Natural History]
Chandra D (2026). [PMID: 29939651](https://pubmed.ncbi.nlm.nih.gov/29939651/). *Unknown Journal*. [Other]
Badrulhisham F (2026). [PMID: 41946532](https://pubmed.ncbi.nlm.nih.gov/41946532/). *BMJ Case Rep*. [Case Report / Case Series]
Haire LE (2026). [PMID: 41588700](https://pubmed.ncbi.nlm.nih.gov/41588700/). *Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc*. [Case Report / Case Series]
AI-curated news mentioning cryptogenic organizing pneumonia
Updated Sep 16, 2026
A recent case series and literature review highlights the occurrence of organizing pneumonia associated with ocrelizumab treatment in multiple sclerosis patients. This finding underscores the need for awareness of potential pulmonary complications in MS therapies.
A case report highlights the association of durvalumab with nephrotic syndrome and organizing pneumonia. This finding contributes to the understanding of potential adverse effects linked to durvalumab treatment.
A case study highlights organizing pneumonia potentially induced by infliximab in a pediatric patient with ulcerative colitis. This finding underscores the need for vigilance regarding rare adverse effects of common treatments.